MEK1 Antikörper (pThr286)
Kurzübersicht für MEK1 Antikörper (pThr286) (ABIN7454494)
Target
Alle MEK1 (MAP2K1) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- pThr286
-
Verwendungszweck
- Goat anti-Phospho MEK1 (T286) Antibody, Affinity Purified
-
Homologie
- Rat,Rabbit,Chimpanzee
-
Aufreinigung
- Affinity Purified
-
Immunogen
- surrounding threonine 286
-
Isotyp
- IgG
-
-
anti-Mitogen-Activated Protein Kinase Kinase 1 (MAP2K1) (AA 2-150) antibody
MAP2K1 Reaktivität: Human IHC (p), IF (cc), IF (p), FACS, IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Mitogen-Activated Protein Kinase Kinase 1 (MAP2K1) (AA 1-100) antibodyMAP2K1 Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Mitogen-Activated Protein Kinase Kinase 1 (MAP2K1) (pSer298) antibodyKD Validated MAP2K1 Reaktivität: Human WB, ICC, FACS Wirt: Kaninchen Monoclonal 24GB285 unconjugated Recombinant Antibody
anti-Mitogen-Activated Protein Kinase Kinase 1 (MAP2K1) antibodyMAP2K1 Reaktivität: Human, Maus, Ratte, Hund, Affe WB, IHC, IF, IHC (p) Wirt: Maus Monoclonal 3H3 unconjugated
anti-Mitogen-Activated Protein Kinase Kinase 1 (MAP2K1) antibodyMAP2K1 Reaktivität: Human, Maus, Ratte, Hund, Affe WB, IHC, IF, IHC (p) Wirt: Maus Monoclonal 2H3 unconjugated
anti-Mitogen-Activated Protein Kinase Kinase 1 (MAP2K1) antibodyKD Validated MAP2K1 Reaktivität: Human WB, FACS Wirt: Kaninchen Monoclonal 23GB2475 unconjugated Recombinant Antibody
anti-Mitogen-Activated Protein Kinase Kinase 1 (MAP2K1) antibodyMAP2K1 Reaktivität: Human, Maus, Ratte, Hund, Affe WB, IHC, IF, IHC (p) Wirt: Maus Monoclonal 3B4 unconjugated
anti-Mitogen-Activated Protein Kinase Kinase 1 (MAP2K1) (N-Term) antibodyMAP2K1 Reaktivität: Human, Maus, Ratte, Xenopus laevis WB, IHC, IF, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Mitogen-Activated Protein Kinase Kinase 1 (MAP2K1) (pSer221) antibodyMAP2K1 Reaktivität: Human WB, IHC, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Mitogen-Activated Protein Kinase Kinase 1 (MAP2K1) (pThr292) antibodyKD Validated MAP2K1 Reaktivität: Human WB, ICC, FACS Wirt: Kaninchen Monoclonal 24GB305 unconjugated Recombinant Antibody
-
-
Applikationshinweise
-
IHC: 1:200 - 1:1,000. Epitope retrieval with citrate buffer pH 6.0 is recommended for FFPE tissue sections.
IP: 2 - 10 μg/mg lysate
WB: Not recommended
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1000 μg/mL
-
Buffer
- Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09 % Sodium Azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Haltbarkeit
- 12 months
-
-
- MEK1 (MAP2K1) (Mitogen-Activated Protein Kinase Kinase 1 (MAP2K1))
-
Andere Bezeichnung
- MEK1
-
Hintergrund
- Background: MEK1 is an activator and kinase for MAP and ERK kinases. It is a serine/threonine kinase essential to the MAP kinase signal transduction pathway which is involved in a multitude of cellular processes such as proliferation, differentiation, gene activation, and development. MEK1 displays 85 % identity with MEK2. Although MEK1 and MEK2 have been found to be functionally similar, they may serve non-redundant functions. Both are required for cellular proliferation and may play a role in tumorigenesis.
-
Gen-ID
- 5604
-
NCBI Accession
- NP_002746
-
UniProt
- Q02750
-
Pathways
- MAPK Signalweg, RTK Signalweg, Interferon-gamma Pathway, Fc-epsilon Rezeptor Signalübertragung, Neurotrophin Signalübertragung, Activation of Innate immune Response, Toll-Like Receptors Cascades, Autophagie, Signaling of Hepatocyte Growth Factor Receptor, BCR Signaling
Target
-
